Mupirocin: a new topical therapy for impetigo.

Abstract

Mupirocin is a new, topical antibiotic effective for the treatment of impetigo. It has a unique structure, mechanism of action, and water-miscible formulation. When it is applied to an infected area three times daily, clinical improvement should be seen in 85% to 100% of patients within 3 to 5 days. It is associated with a low incidence of adverse effects and cross-resistance. Further studies are necessary to define the exact role of mupirocin in treating other primary and secondary cutaneous infections.

• Authors: C D Putnam, M S Reynolds
• Journal: Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners (J Pediatr Health Care) 1989 Jul-Aug Vol. 3 Issue 4 Pg. 224-7 ISSN: 0891-5245 [Print] United States
• PMID: 2502615 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Anti-Bacterial Agents
• Fatty Acids
• Mupirocin

Topics

• Administration, Topical
• Anti-Bacterial Agents (therapeutic use)
• Clinical Trials as Topic
• Fatty Acids (administration & dosage, pharmacology, therapeutic use)
• Humans
• Impetigo (drug therapy)
• Mupirocin